Parametrica Management LTD Vertex Pharmaceuticals Inc Transaction History

Parametrica Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $191,079 - $222,729	-923 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $191,070 - $254,831	923 New	923 $218,000
Q1 2019 May 07, 2019	SELL	$163.73 - $194.7 $267,862 - $318,529	-1,636 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$151.91 - $192.21 $248,524 - $314,455	1,636 New	1,636 $271,000
Q4 2017 Feb 01, 2018	SELL	$137.28 - $155.55 $268,245 - $303,944	-1,954 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$148.13 - $162.24 $289,446 - $317,016	1,954	1,954 $297,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.